Sunday, July 11, 2021 1:41:25 PM
600M in debt and it was bought for 12B. We have a tiny fraction of that in debt! Does that mean we have that big of a runway to raise for advancement? Bingo!
And not to mention our IP is multiples better. $20B? $50B? Boom boom a vroom.
Dont let anyone fool you into our IP being untested. What did Chemdiv do? Hello? And thats just one of many arguments. What was the nature of Eli Lilly and Regen collaboration? Was it not active research? Testing of molecules, to be specific? Yes. Yes it was.
Dont be fooled!! Know what you Own!
Amazing contribution Carter. Much Appreciated!
And not to mention our IP is multiples better. $20B? $50B? Boom boom a vroom.
Dont let anyone fool you into our IP being untested. What did Chemdiv do? Hello? And thats just one of many arguments. What was the nature of Eli Lilly and Regen collaboration? Was it not active research? Testing of molecules, to be specific? Yes. Yes it was.
Dont be fooled!! Know what you Own!
Amazing contribution Carter. Much Appreciated!
Sometimes its Skil, Sometimes its Luc.
I Appreciate All Member Follows!
Desperate Sellers Become Desperate Buyers. Vice Versa
ALL IMHO.
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
